Aurora Cannabis’s Earnings Outlook

Aurora Cannabis (NASDAQ:ACB) is set to give its latest quarterly earnings report on Thursday, 2023-08-10. Here’s what investors…

Aurora Cannabis (NASDAQ:ACB) is set to give its latest quarterly earnings report on Thursday, 2023-08-10. Here’s what investors need to know before the announcement.

Analysts estimate that Aurora Cannabis will report an earnings per share (EPS) of $-0.08.

Aurora Cannabis bulls will hope to hear the company announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Past Earnings Performance

Last quarter the company missed EPS by $0.13, which was followed by a 1.45% drop in the share price the next day.

Here’s a look at Aurora Cannabis’s past performance and the resulting price change:

Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022
EPS Estimate -0.05 -0.06 -0.09 -0.16
EPS Actual -0.18 -0.15 -0.13 0
Price Change % -1.45% -1.09% 16.79% -7.14%

eps graph

Stock Performance

Shares of Aurora Cannabis were trading at $0.5537 as of August 08. Over the last 52-week period, shares are down 66.12%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.

To track all earnings releases for Aurora Cannabis visit their earnings calendar on our site.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Why Is Retail Technology Company Diebold Nixdorf’s Stock Jumping Today?

Discover Diebold Nixdorf Inc's Q1 FY24 sales growth, surpassing analyst expectations. Banking revenue soared by 9.4%, while Retail revenue faced a slight decline. Despite a marginal drop in gross profit, operating income surged, indicating enhanced profitability. CEO Octavio Marquez emphasizes the company's solid start in 2024, focusing on expanding gross margin and free cash flow.

DBD